Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome

Brain Research
A ColakH D Shine

Abstract

We evaluated the efficacy of adenoviral-mediated gene therapy of experimental spinal cord tumors and the functional outcome after this treatment. Spinal cord tumors were generated in the thoracic region of the spinal cord in Fischer 344 rats by stereotaxic intramedullary injection of 1 x 10(4) 9L gliosarcoma cells. Seven days after tumor cell injection, a replication-defective adenoviral vector carrying the herpes simplex virus thymidine kinase gene (ADV-tk) or a control adenoviral vector carrying the beta-galactosidase gene (ADV-beta gal) was injected into the tumors. Beginning 12 h later the animals were treated with the antiviral drug ganciclovir (GCV; 50 mg/kg) or saline twice a day for 6 days. The neurological performance of the animals was assessed during and following treatment. Eighteen days after tumor cell injection, all of the control animals had paraplegia and large tumors. In contrast, no tumors were detected in animals treated with ADV-tk and GCV. In long-term studies, two of the 5 animals treated with ADV-tk and GCV remained tumor-free and remained neurologically intact at 6 months whereas all animals in the control groups became paraplegic within 18 days.

References

Feb 21, 1990·Journal of the National Cancer Institute·F L Moolten, J M Wells
Jan 1, 1981·Journal of Neurology·M WeizsaeckerM Barker
Nov 1, 1994·Journal of Neuroscience Research·M J Perez-CruetH D Shine
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·S H ChenS L Woo
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M CarusoD Klatzmann
Jul 1, 1993·Journal of Neurosurgery·Y TakamiyaR L Martuza
Nov 1, 1993·Journal of Neurosurgery·D BarbaF H Gage

❮ Previous
Next ❯

Citations

Aug 11, 1997·Advanced Drug Delivery Reviews·D T Curiel, C Rancourt
Oct 30, 1998·Critical Reviews in Oncology/hematology·M A Roskrow, B Gänsbacher
May 26, 1999·Human Gene Therapy·M C BohnD E Redmond
May 7, 2010·Clinical and Translational Science·Thais FedericiNicholas Boulis
Sep 8, 1999·Journal of Vascular Surgery·M SakuraiK Tabayashi
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·T W TraskR G Grossman
Mar 31, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·John S WinestoneFrederick A Boop
Feb 21, 2002·The Oncologist·Stephan A Vorburger, Kelly K Hunt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.